MRK

Humungusminimaglight

MRK their joint developer are up 12%

SilenttKnightt

Why is MRK not getting the love that Mederna is?

Plus-Concept9394

Don’t forget about MRK

Stop_The_Rain

MRNA & MRK find a cancer treatment.... MRNA up 90%.... MRK up 7%.... there is your difference between US and EMEA markets....

MartianInvestor

MRK

isospeedrix

You can’t make this shit up. Tickers starting with MR are mooning. MRNA MRVL MRK

BlueSkysnBlueChips32

Bought MRK's dip yesterday.. Earnings slightly better than expected this morning... Hopefully it's not down again because of greedy over expectations 🙃

Mindless_Sky_6654

MRK is gonna pump even more (I have a shit ton of MRK)

Got_Engineers

REITs and healthcare. REITs AMT WELL O HEALTHCARE PFE MRK Made 300% on July calls for PFE. I used to work in the pension industry at a very large investment fund and I’m quite familiar with how they rebalance throughout the quarters. My personal theory is that there has been a rotation with options where companies are not placing long-term bets and are using options to target more specific exposures on shorter time frames like 1 to 3 months to stay within a quarter. Something like 80% of all QQQ options are less than one week of expiration right now. Each quarter end option expiration seems to be larger so I have noticed that these cycles of lower beta assets seem to rotate ahead of the rest of the crowd. Same with XLE energy. Take any of the sector ETF and look at the top 10 companies and all I’ve done is pick one or two of them that seemed to have options volume or and cyclical volatility on the 1H and 1D charts. Just like anything in life such as a sports team or your own dog if you intimately track it and observe its patterns and moves every single day you’ll probably pick up some tendencies and repeated patterns. REITs don’t have a premarket or post market generally so that itself is divergence from the norm and has game theory components. Are stocks with less volume and less market hours still traded the same algorithmically? You’ll have to find out.

Got_Engineers

Real estate REITs and healthcare? I’ve made like 500% on O realty calls and Pfizer calls lately. PFE has gapped up the last week. Find companies in the top 10 of a sector etf and track them. Healthcare MRK ABBV PFE GILD REITs O AMT WELL

Happy-Champion1661

MRNA JNJ MRK LLY honestly literally this is the only one that went surprisingly down instead of up, it's a pure value play at this point, it didn't do what it was supposed to do together with the sector. I got few jan28 calls, they are down 20%. Shares might have been a better play idk

ninjaguy2511

CVI stock. NOt only does it play with me more than ex situationships, but I could of gone more into MRK when it was 70. I still got a lot when it was, but if I put the extra 5 grand man with the dividends oh boi id be good. Now every time I wanna sell it there is hope and than it just crushes my country balls.

GoPackGo16

MRK and ZTS are selling screw worm medications like hot cakes in Texas.

MeYouThemEveryone

Oh great, now Ebola is spreading. Calls on MRK for vaccines

zangor

True but let’s see in a year from now. I think the share price will not go much lower. I did this with MRK last year to hold cash and that went well. But CLX could keep dropping I suppose.

iMakeGOODinvestmemts

Merck & Google Cloud partner to accelerate agentic AI. $MRK $GOOGL

Desperate_Stretch855

Don’t listen to people who have no idea what they are talking about. Taking a salary means paying taxes- not doing some defers taxes. I’d work on getting him to focus on building a diversified portfolio of large cap and profitable companies first, before moving onto something like this. A lot of time it’s not “is this a good stock to buy?” But “is this the BEST stock for ME to buy?”. Take a look at stocks like: AVGO MSFT GOOGL BRK B MRK JPM

ballistic762

I fucking hate Novo Nordisk. Competition in the pharma game is absolutely brutal, and Novo Nordisk is getting absolutely smoked because of their comically lazy workforce. Their R&D teams are a running joke from what I understand. productivity levels that make government bureaucrats look like workaholics. While $LLY & $MRK in the US are grinding 60-80 hour weeks, pushing boundaries, and actually innovating, Novo’s crew is clocking in for cushy 9-5s (when they bother to show up), burning through endless PTO, stacking maternity and paternity leaves like it’s a competitive sport, and coasting on fat payroll with rock-bottom expectations. Most of them are straight-up checked out: relaxing, phoning it in

Top-Composer-9585

MRK and TERN are merging, pump incoming

Shoddy-Usual1070

I didn't see any blood yet I have a long-term portfolio KO, MRK T BP WMB .Most were up today..

Mindless_Sky_6654

MRK has been carrying me the whole year

Interesting-Tap-4402

it will past 100 bucks! MRK will buy it

Interesting-Tap-4402

25 billion buyout base case by MRK. over $100 per share. Congrats bro

Interesting-Tap-4402

same thinking as well. This types of assymetry so obvious rarely happens, MRK needs GPS to make their keytruda not to become generic. Keytruda was 50% if not more of MRK revenue, they will do whatever it takes for others to not even bid. The fact that Revolution Medicines deal didn't workout shows that MRK was willing to pay 28-32 billion for drug without Phase III data. I easily see 25 billion base to 60 billion buyout. MRK will be nothing without GPS

stayfun

Massive quantities of MRK options bought in last hour. 

BNA-mod

SSO - 2008 NVDA - 2009 LLY - 1999 (bought in with my father) MRK - 1982 (got my mother to buy) 😂 AMZN - 2010 CSX - 1999 (my uncle recommended investing in railroads and it was dirt cheap)

Shoddy-Usual1070

KO BP MRK WMB T Been good to me

Emotional-Breath-838

People don't realize that DRTS didn't just receive PMDA approval - they got a seven year exclusive on the market. With Merck forming a separate cancer division, one of two things will happen: 1. Merck and DRTS partner to extend Keytruda viability/efficacy. $MRK has massive distribution for their $30B baby. 2. Merck takes out DRTS in M&A. Given the latest radiotherapy M&A, I expect we would see a $4B floor and a $5-$6B deal. (N.F.A./D.Y.O.R.)

ArmadilloOk2118

Hey Jensen will you do anti-cancer nanobots in the future, or should I bet on MRK. JNJ or PFE instead?

Ok-Tennis330

https://preview.redd.it/ema1fzdxfblg1.jpeg?width=528&format=pjpg&auto=webp&s=878f7053c348a01b1808202a10668c1afa7b8d55 “Now pump MRNA, MRK, JNJ, LLY, but not NVO”

Mindless_Sky_6654

MRK’s all time high is in the 130’s.

Available-Range-5341

Damn, I usually do dividend stocks and it's weird to see AEP yielding < 3%, JNJ yielding 2.2%, AMGN and MRK yielding < 3% Historically horribly value proposition.

Available-Range-5341

I owned MRK from OCt - Nov if you want to SMH. Wall St HATED them but I thought I was calling a bottom. My position went slight green then Wall St. started churning out news that they're the worst company ever so I sold at it started dipping one day Suddenly they're up 26% from there in two months? Almost like Wall St lies constantly so why I don't trust this "software is dead" bullshit That's just one example of many

AJ_Grey

MRK is one little green island in my red sea portfolio

MitchCurry

Buffet bought back $25B in BRK stock, opened new positions in BMY, PFE, ABBV, MRK, and B, spent $B on Dominion's natural gas infrastructure, and added to existing positions. What in the world are you talking about? Just because he didn't spend all his cash doesn't mean he bought nothing.

AnotherPassword239

MRK, PFE, XOM, MSFT, VZ Hopefully SPXC but need to add some more

Run4theRoses2

The recent Market Action is telling all who don't know or who aren't sure, - Gps is 100% for Sure Getting FDA Approval and that SLS is worth F Ton More than what shorts sold it Down for - What is GPS TRULY WORTH? Incoming Phase 3 Results for GPS Immunotherapy are offering a true Once in a Lifetime Investment Opportunity. $.64b Manipulated Market Cap worth $40B to Big Pharma the Instant the Phase 3 Results are Announced. **- The Value of a Positive Phase 3 Result exceeds $40B, more than 77x the current manipulated $.6b mcap. SLS Share Price will continue climbing until the P3 Results are released, and then it Launches.** \- Big Pharma's Pay 4X Revenue Multiples in buyouts. \- 12,500 AML CR2/CR3 Patients Each Year\* - current P3 Setting. SLS published est\* rev per patient of $280K /year. ​\*\*- $3.5B Year 1 TAM\*\* Currently 5-7,000 AML CR2 Patients Who Also Will Be Immediately Eligible for Gps Immunotherapy right out of the Gate upon approval: 5,000 \* $280k = $1.4B **Year 1 Total Addressable Market $4.9B** for Just for AML CR2/3 - the Setting for the Phase 3 Trial. AND THEN COMPOUND IT - Infinite Dosing to Until Relapse \- Year 1 Rev $280K Per Patient / 15 Doses - Year 2 Rev $112K Per Patient / 6 Doses \- Year 3+ Rev $70K Per Patient / 4 Doses the Ad Infinitum Dosing Regime Doubles the Total Addressable Market for AML CR2 CR3 Then Add AML CR1/ Post ASCT - 5X the SIZE of CR2/3 Esp w VIALE-M CR1 Trial Failing and VIALE-T P/Asct Failing. **You absolutely Know Big Pharma Will be Adding AML CR1 Patient and AML Post Asct Patient Populations to the Potential Revenue Calculations.**Gps will be Effective in over 20 different cancer settings that harbour WT1 +. GPs has already proven effective in Mesothelioma and Platinum Resistant Ovarian Cancer settings, achieving better Phase 2 Combination trial Results with Keytruda $MRK - MOS of 18.4 months - than, Elahere $IMGN 16.4 Months, which earned FDA Approval and was bought by $abbv for $10.1B - this is just 1 comp worth $10B. \* Sources available upon request \-- ABVX was a $5 and change Equity prior to releasing its Phase 3 Trial Results - it launched on the P3 announcement - T1 Trading Halt and a Gap UP opening at $60 and it Kept on Climbing to a high of $145. \- buyout expected/

Anxious_Cheetah5589

Probably true in mega cap tech. Stodgy dividend payers have done very well lately (PFE, CAT, JNJ, WMT, MRK, VZ, etc). It feels like a collapse if you're overweight tech, but it's really just a healthy rotation.

Bsweezey817

I’m up 10% YTD. I own far more MRK than I should. I’ve started to sell a little bit but it feels wrong. Wondering if I should just hold all of it for now.

Happy-Champion1661

went 0/5 with earnings this week the only put I bought was on MRK lmao

zbern

LLY is a breath of fresh air for my LNTH holding. NVO, PFE, and MRK are all either suffering from competition, soon to be expired patents, and scrambling to disassociate with China/India manufacturing. Also u/_hiddenscout turned me on to this article and it blew my mind. https://fortune.com/2025/06/17/novo-nordisk-ozempic-wegovy-semaglutide-canada-patent-protection-fee/](https://fortune.com/2025/06/17/novo-nordisk-ozempic-wegovy-semaglutide-canada-patent-protection-fee/

Happy-Champion1661

MRK puts and it pumps PFE NVO LLY red LMAO at least my PFE strangle printed

Mindless_Sky_6654

MRK!

jglhk

Honestly surprised MRK is booming. Not sure if it will last.

stickman07738

I always viewed PFE as an acquirer and not innovative - some acquisition went well but most were poorly done. I was really liking the Seagen acquisition but I now have my doubts and still watching from the side-lines. MRK is another story and too tough for me to call - for me, this is the break year for the CEO.

zbern

MRK and PFE didn’t have bad earnings from a numbers standpoint, but the guidance from both did not bode well for the US healthcare in the mid-term length. Looks like a lot of patents are coming up on expiration and companies are buying up smaller biotech/pharma companies because of it. Also, both are mentioning uncertainties with the current administration’s take on healthcare in general. And, it seems the ‘American First’ onshoring efforts in general are playing a big factor right now with trying to become less reliant on China/India manufacturing.

Happy-Champion1661

MRK puts, PFE straddle, PEP puts at open thinking about UBER calls, anyone?

Happy-Champion1661

MRK pump is so sus, no way it's not gonna dump right? just fuk the puts before ER

xfolder254

for tomorrow my guesses are 🍏 $PLTR $PYPL $NXPI $IT 🍎 $PEP $PFE $MRK $TER $RMBS

Stocks_N_Bondage

Opened today: - Calls: ATI • BALL • NXPI • RMBS - Puts: MRK • PEP • PLTR • PYPL (Also holding a position in RMBS) Re: PLTR, might make it a strangle by eod. Kinda on the fence here, but it's below the 200 day MA for the first time since it was $7 with earnings decelerating. *Disclaimer: don't do what I do, but if you do, I mostly work with strikes around delta 25 ish*...

Ok-Elevator9738

Sounds good u/LabDaddy59 I should be able to share my tracker in a day or two, and we can connect after that. I’m also very interested in LEAPS; I saw your comments in a LEAPS thread and would definitely appreciate picking your brain. I have a handful of names (AAPL, ASTS, BACS, BRK.B, GOOGL, MRK, NFLX, NVDA, SPY) that i opened leaps in the recent past, with some i'm doing PMCC. Would love to understand how much of my portfolio I should keep for Leaps, and also how im choosing my trades (currently my LEAPS screener focuses on deep ITM calls (delta \~0.70–0.85), long DTE (\~9–18 months), low IV / IV Rank (preferably <30), low extrinsic value (<6–8%), strong liquidity (high OI), and high-quality businesses suitable for stock-replacement and optional PMCC.

dvdmovie1

If I was going to add a big pharma co would probably be MRK. I also appreciate them being the buyer in a couple of the biotech names I've had bought in the last few years (VRNA, RXDX)

AJ_Grey

MRK has had a nice run over the last few months but the news on the Moderna/MRK skin cancer trials strikes me as significant. I have a small position but I'm kicking the tires on adding more.

DisastrousPlantain51

So why would this stock in your opinion go to 100 from 6 dollars? Compared to NVO PFE MRK other related pharma stocks?

Dritzz-9966

They likely tried already behind closed doors (offered 10B for MTSR, which is VERY inferior to VKTX and a lot further behind). However VKTX's management probably is asking for 25-40B in a buyout scenario (which is a huge premium on today's share price, but is what the company would be worth for VK2735). So it's a lot in the look of it. If you do a buyout for a 1200% premium, maybe the shareholders (who aren't necessarily knowledgeable in bio data) will not be happy. That's the only reason. You are right, I am extremely bullish on VKTX, see my last WSB DD on my profile for more info. I will also become extremely bullish towards the company that acquires or partners with VKTX and will buy a large position. This is because NVO/ABBV/MRK have a really good supply chain and marketing, they are just lacking a good product.

Anxious_Cheetah5589

"Small dogs of the dow" .... Currently KO VZ PG NKE MRK. Dogs of the Dow are the 10 highest yielding stocks in the Dow. Small dogs are the 5 lowest priced of those 10. Big, liquid, well known, well understood, predictable. Sometimes they blow up, but very rarely.

Emotional-Breath-838

$DRTS is an FDA darling, doing Skin, Prostate, PanC, GBM, and breast with or without $MRK Keytruda.

ShareholderSLO85

I have hopes for PFE, MRK and BMY.

wenb1

How about MRK?

I_likeVr

Why did MSKCC license their GPS program out? Why did MD Anderson terminate their sponsoring of GPS Osotspa failed their Phase 2 and nether bothered to start another one Also why did MRK and BMY bail on GPS combo trials instead of advancing to Ph3? Why did 3D Med skip paying the milestone to in-license it? It is because the data just was not good enough.

Even-Equivalent-5818

For MRK the trial was meant for ovarian cancer. From what I can tell the trial ended up being positive, but not enough for Merck to continue as that indication is is a very competitive one. As for BMY that trial was meant to exist as a proof of concept and was meant to progress used for registration. It was a collaboration setup by a third party research org. In case anyone is interested the study showed participants living three times longer when taking both companies products than without. Hope this helps, please stop spamming the same post everywhere.

Resident-Area5907

Really? I thought the first patient started 45 months ago? Anyway, YOU should be able to answer my really basic questions here: Why did both MRK and BMY run away, instead of continuing their collaboration trials into Phase 3? Why did 3D Med decide that GPS wasn't worth paying the milestone to get? WT1 was always a great target in theory. But there are no approved peptide oncology vaccines, in spite of numerous attempts (e.g. Sellas' old asset NPS, that Stergiou used to say that he was on the verge of selling "to an Asian company" but now has become the "let us never speak of that again" subject in SLS). We can't just use "historical controls" to tell whether GPS is working, because trial patients are screened for comorbidities. Why didn't the three companies that had inside information on GPS get interesting in continuing collaboration with Sellas? And why did Stergiou say that he "didn't want to have all his eggs in the GPS basket" back when he bought SLS009? I'd like to have a bigger position here... but whenever I ask these basic questions, I just get obscenities and death threats instead of answer. TIA to anyone who can clear this up, I imagine that someone here can.

Resident-Area5907

I hope now that we have more people looking at Sellas, someone that has done more DD (and that isn't from Lidingo) will be able to answer the obvious questions here. Why did both MRK and BMY run away, instead of continuing their collaboration trials into Phase 3? Why did 3D Med decide that GPS wasn't worth paying the milestone to get? WT1 was always a great target in theory. But there are no approved peptide oncology vaccines, in spite of numerous attempts (e.g. Sellas' old asset NPS, that Stergiou used to say that he was on the verge of selling "to an Asian company" but now has become the "let us never speak of that again" subject in SLS). We can't just use "historical controls" to tell whether GPS is working, because trial patients are screened for comorbidities. Why didn't the three companies that had inside information on GPS get interesting in continuing collaboration with Sellas? And why did Stergiou say that he "didn't want to have all his eggs in the GPS basket" back when he bought SLS009? I'd like to have a bigger position here... but whenever I ask these basic questions, I just get obscenities and death threats instead of answer. TIA to anyone who can clear this up, I imagine that someone here can.

Resident-Area5907

I hope someone that has done more DD (and that isn't from Lidingo) will be able to answer the obvious questions here. Why did both MRK and BMY run away, instead of continuing their collaboration trials into Phase 3? Why did 3D Med decide that GPS wasn't worth paying the milestone to get? WT1 was always a great target in theory. But there are no approved peptide oncology vaccines, in spite of numerous attempts (e.g. Sellas' old asset NPS, that Stergiou used to say that he was on the verge of selling "to an Asian company" but now has become the "let us never speak of that again" subject in SLS). We can't just use "historical controls" to tell whether GPS is working, because trial patients are screened for comorbidities. Why didn't the three companies that had inside information on GPS get interesting in continuing collaboration with Sellas? And why did Stergiou say that he "didn't want to have all his eggs in the GPS basket" back when he bought SLS009? I'd like to have a bigger position here... but whenever I ask these basic questions, I just get obscenities and death threats instead of answer. TIA to anyone who can clear this up, I imagine that someone here can.

Resident-Area5907

I hope now that we have more people looking at Sellas, someone that has done more DD (and that isn't from Lidingo) will be able to answer the obvious questions here. Why did both MRK and BMY run away, instead of continuing their collaboration trials into Phase 3? Why did 3D Med decide that GPS wasn't worth paying the milestone to get? WT1 was always a great target in theory. But there are no approved peptide oncology vaccines, in spite of numerous attempts (e.g. Sellas' old asset NPS, that Stergiou used to say that he was on the verge of selling "to an Asian company" but now has become the "let us never speak of that again" subject in SLS). We can't just use "historical controls" to tell whether GPS is working, because trial patients are screened for comorbidities. Why didn't the three companies that had inside information on GPS get interesting in continuing collaboration with Sellas? And why did Stergiou say that he "didn't want to have all his eggs in the GPS basket" back when he bought SLS009? I'd like to have a bigger position here... but whenever I ask these basic questions, I just get obscenities and death threats instead of answer. TIA to anyone who can clear this up, I imagine that someone here can.

Apprehensive_Two1528

MRK, Abbv, MO

Kachowxboxdad

I have a bunch of MRK too! Vici and MRK should have a good 2026

zangor

I opened up a high yield savings account for my cash and struggled to try to have SOFI give me 4% on my cash, couldn’t figure it out without direct deposits that come from an employer. Eventually I got frustrated and was like wait won’t buying VICI and MRK just have a much better outcome. So I did that.

GoPackGo16

You have a problem. Also, no, because a have CVNA puts and MRK calls.

Thin-Ingenuity-728

One person once told me: "You can make a lot of money in the stock market but you can also lose a lot and sometimes everything! So by what is solid like a drug company like MRK. But remember to not put everything in the market and only invest what you are prepared to lose in the event the stock doesn't do well!" There are a lot of excellent advisors out there and there are people that have been lucky but many of these people don't really have any special knowledge but might encourage you to invest in something they invested in hoping it will do better the more investors he gets to buy in to the stock they're interested in. If you are new to the market, perhaps an advisor would be the best way for you to go unless you want to take the time to research things yourself. I always double check things before I buy anything - even when my advisor recommends it. 

PalpitationSmooth992

NEE PCG NIO QCOM VG MRK notice how these arent dumping this is your chance to buy calls

Wise_Ad_1641

best decision of my life was to rotate out of tech and into healthcare and pharma. REGN, LLY, MRK and INSM have paid big

PerfectInAllThings

My LLY, MRK, UNH, JNJ, etc., are all up today

BigWarning8696

I can't find anything on it either. I suspect they may be bought out by MRK, JNJ, or LLY since they are also in the ulcerative colitis field, but that's just a guess. Looks like they are running out of money to finish their trials

ThinkingOfTheOldDays

I was the top tick on MRK. beat that.

Cracked_Tendies

Well here's my main question I guess. Does a protective put pause the holding on the underlying stock? Btw tickers are MRK/UNH. Still feel they're both undervalued but decided to transition my portfolio away from single stock positions so I can increase leverage confidently

JimmyInvestor

I really like MRK. I think the market is pricing in the worst-case scenario for the company. I talk more about it in my newsletter - if you want to check it out, just let me know and I’ll send you the link.

ChicagoanPizza

All these LEAP ideas of yours can play out, but it's not like these stocks are screaming to be bought. MSFT atleast has 200MA bounce (which is more of a short term play for the bounce), but it's not like these stocks are getting into extremely oversold *must buy* opportunities or even really close to it. I'd argue these stocks are still more overvalued compared to undervalued. As I said previously pharma has actually been undervalued and LEAPs on $MRK are worthy of playing for that reason.

Bajatraveler1

Glad I bought MRK instead of Pfizer.

DCHamar

Some biotech companies like MRK and REGN are having a stealthy bull run but nobody is talking about them

Got_Engineers

Someone dumped a bunch of money on some January or February calls. Let me find the details. It was unusual volume. Same with $MRK.

PalpitationSmooth992

MRK is unstoppable my Jan 100c are up over 2000 percent in the past 2 weeks

New_Ad_1682

I have a rule. Whenever a stock I own is not more than 10% of my portfolio and it goes up 20%, I always double my exposure. I got to do this with MRK today. Feels good man. Feels really good.

zangor

I did not expect MRK to give tech stock level returns.

tachyonvelocity

Eh, it's not valued like it's going out of business, but is now close to other big pharma companies. I should've just bought more MRK when it was trading at <9x forward, which was close to the 2008 lows. But NVO is compelling now.

tachyonvelocity

Not sure why I started a position in NVO honestly. MRK and REGN both have obesity drug pipelines and traded cheaper. REGN not anymore. MRK still cheap. Both of these positions are up massively.

PalpitationSmooth992

here is why you always go long my MRK Jan 100c were worth .3 just a couple weeks ago they are up almost 2k percent and still have almost 2 months left

anon10751075

I understand that "controllable" and "consistent" are like oil and water with 1dte options because of volatility and action being so quick on them. However I don't know how to explain it other than I'm sitting here at the desk, able to flip between 30 sec, 1 min and 5 min charts - see the trend real time and enter / exit the option that I want instantly. The majority of my positions I'm only in for a matter of minutes - riding 15 minute up or down trend and then existing with a 15-20% premium scalp. To me - this has been much easier to "control" my premium risk with regards to entry price than with trying to time long call entry points. I feel I was only successful on those because I was able to identify for instance AAPL and MRK 50/200 SMA cross overs and load up on favorable long calls. Hope that makes sense?

ChicagoanPizza

I've never been much of a LEAP person, but if I were going to play a LEAP, something I added big time to my long term and might sell some now lol is $MRK and maybe the healthcare sector in general. Faced some political risk, is arguably undervalued, has the chance to really bounce back. I'd maybe also look at emerging markets, maybe China? $BABA? Though there's a bunch of potential for political risk.

OnceALoser

Maybe I should build a dividend portfolio of underperforming stocks like MRK PFE TGT. With rates down, investors will be flocking to high dividend stocks.

Mindless_Sky_6654

Good few weeks to be a MRK bag holder

unwanted_hair

Wish I held my MRK, LLY, and REGN shares. Those gains would be offsetting my losses today.

Conny-Bravo

Big flows from yesterday I followed: Path 12/19 15c, MRK April 100c, and UNH March 400c. Also a ton of AAPL 11/14 277.5c came in right at the close.. Gonna be an interesting day

eoiioe

Whichever wsb user said buy puts on MRK as they deal will be scrapped for this week, hope you step on Lego all of December lol

Me-Regarded

I pick earnings lotto tickets wrong every time. MRK over LLY. It's almost comical

jeffrr

MRK beat and goes down like its a tradition. The same shit happened last earnings, i swear.The stock is scared to go higher.

Gl5778

Please be aware I do have a potential conflict of interest here because I own over 1,000 shares of NWBO. You need to know how to read research papers, how to verify sources, and most importantly any tiny thing that you can use to tear them apart. While also being able to think like an investor. The burden of proof is on those who publish and not the reader. All it takes is a 👍 or 👎 from a group of regulator’s. One you make an assload of a gains the other near certain catastrophic loss in the stock you have. These are not MRK, GSK, J&J, and LLY that can /will soak up billion dollar losses on a drug and still have 40 others in the pipeline Will maintaining profitability. Small biotechs are very vulnerable to data manipulation, fraud, and regulatory scrutiny. I mean you need approval for profit. (Or a buyout) You have Assholes who will defraud people at all costs. Then the FDA is notorious for picking on the little guy. They don’t have the big legal teams. Only invest in if you trust the data and the conclusions that other professionals completely unrelated to the study have come to. Per google there are issues with NWBO’s study. “the company made fundamental changes to the trial design, used questionable statistical methods, and demonstrated a profound lack of transparency” The changes and statistical methodology is fine if it can be verified and replicated in other trials. The lack of transparency is a huge problem with the company. It is the big thing that makes me nervous. Anyway just my thoughts on NWBOz

NOT_MartinShkreli

I’d go long on GMAB, GILD, HALO, EDIT, or TAK before MRK

First_Newspaper129

Why on MRK?

NoMorning5015

I've got ETN as my largest position, almost by accident...bought long ago and it just surged. I wish I had built a growth portfolio out of ETFs. As of right now only 1/3 of my brokerage is in ETFs and mutual funds and the rest is individual positions. Right now I am feeding SCHG monthly, and slowly building a position in MRK, which I'll likely do until it hits $100/share.